permatology

How we structured the entry of a K-Clinic brand in Brazil

Regulation, scientific narrative and channel as drivers of medical adoption

This project was fully conducted by Kiko Sori, the strategic partner in the “Brazil Market Gateway” project.

permatology

How we structured the entry of a K-Clinic brand in Brazil

Regulation, scientific narrative and channel as drivers of medical adoption

This project was fully conducted by Kiko Sori, the strategic partner in the “Brazil Market Gateway” project.

context

Permatology is a Korean high-performance dermocosmetic brand focused on tissue regeneration technologies such as PDRN.

Positioned at the intersection of dermocosmetics and clinical practice, the brand required strong scientific legitimacy, medical endorsement and structured market access to succeed in Brazil.

Challenge

The objective was to enter the Brazilian market with a clinical and premium positioning, ensuring alignment across key strategic fronts:

  • regulatory compliance
  • scientific narrative
  • commercial strategy
  • professional distribution channels

In parallel, the launch of a new regenerative protocol, Glass Skin Protocol,  demanded not only communication, but also medical education and structured adoption within the clinical ecosystem.

market entry model
Kiko Sori structured the market entry based on four integrated pillars:
01. Regulatory Validation

ANVISA registration and regulatory compliance, ensuring legal security and enabling commercialization in Brazil.

02. Scientific and Technical Narrative

Translation of PDRN technology into a clear and credible value proposition for medical professionals.
Positioning aligned with clinical practice and premium perception.

03. Medical Channel Structure

Definition of the go-to-market strategy within the medical channel.
Development of pricing logic, professional distribution and portfolio alignment.

04. Medical Relationship and Adoption

 Activation of key doctors and clinics, especially in São Paulo.
Implementation of education, training and certification to drive adoption.

 

our impact
In clinical categories, growth is not driven by visibility. It is driven by structure.

Adoption occurs when regulation, scientific narrative, channel strategy and medical relationships are developed simultaneously, turning innovation into clinical practice.

Within 2 months:

+40 active physicians

+ 23 clinics onboarded

+300% monthly revenue growth

Certification program implemented with institutional networks: AFYA and Inspirali

Presence across 7 Brazilian states: SP, RJ, MG, BA, PR, MT and SC

GET IN TOUCH

Ready to launch your brand in Brazil?

@new.thinksaude.com.br
Somos
especialistas no mercado de beleza, estética-médica e bem-estar.
Projetos de marketing integrado. Do posicionamento ao crescimento comercial.

ATENDIMENTO PRESENCIAL
São Paulo e Porto Alegre

COMERCIAL
contato@new.thinksaude.com.br